BillionToOne, Inc. - 10-Q Filing

BillionToOne, Inc. reports Q3 2026 financial results including segment data for Prenatal, Oncology, and Clinical Trial Support.

SEC EDGAR ·

Tickers: $BLLN

Read the full article at SEC EDGAR

More Regulatory news